Study paste to prevent narrowing in new arm dialysis fistulas
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This Phase 1 study tests a treatment (called AMSCs) to help stop scar-like narrowing at the connection point of a new arm dialysis fistula. If it works and is safe, it could improve long-term fistula function so dialysis can work better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old
- You are currently planning to get a new arm dialysis fistula (AV fistula) with suitable anatomy
- You can talk with the study team, follow study visits, and sign consent
- You are expected to live at least 24 months
- If you can get pregnant, you must be post-menopausal or unable to have children (or you must pass a pregnancy test)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special ultrasound implant (EchoMark) helps a new dialysis fistula mature properly. It involves people with advanced kidney disease who are starting or already on dialysis and are having a fistula created in the upper arm.
This trial tests a special wrap placed around a new arm access point for dialysis (called an AV fistula) to see if it helps the access stay healthy and work better. It is for people who need a new AV fistula for kidney dialysis.
This study looks at blood flow and sounds in new arteriovenous fistulas (AVFs) during dialysis. If you need a new AVF in your forearm, this trial may help doctors understand how to make your fistula work better.
This study tests a small mesh support called VasQ that is placed around your new fistula to help it heal and stay open longer. It is for people who are getting a new fistula for dialysis access.
This trial tests a new type of dialysis access graft (called aXess-E) for people with kidney failure who need a graft in their arm. It aims to see if the graft works well for long-term dialysis.
This study monitors how well the BD WavelinQ endoAVF device works after routine clinical use. It may help people who need a dialysis access fistula by sharing real-world safety and performance data.
Hear when a new End Stage Renal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.